A paper published today in the journal Science explores the potential of glucagon-like peptide-1 (GLP-1)-based drugs such as semaglutide to treat diseases beyond diabetes and obesity. For example, recent studies suggest that they could improve conditions ranging from depression to neurological disorders to cardiovascular and kidney disease.
The use of the antidepressants escitalopram, paroxetine, and duloxetine is associated with greater weight gain than the use of sertraline, according to the results of an analysis comparing data from more than 183,000 adults treated with one of eight types of antidepressants. Among these, bupropion is associated with the least weight gain, concludes the study, which is published in Annals of Internal Medicine.
About one in 5,000 people have a genetic variant in the SMIM1 gene that results in a particular type of blood type called Vel negative. An international team of researchers now describes the same variant as being associated with a predisposition to obesity, metabolic disturbances and lower resting energy expenditure. Women studied with the variant weigh, on average, 4.6 kg more, while in men the difference is about 2.4 kg. The results are published in the journal Med, published by the Cell group.
The Spanish Agency of Medicines and Health Products (AEMPS) has announced that the anti-obesity drug Wegovy (semaglutide) will be available, with a doctor’s prescription, starting from May. It is the same active ingredient as Ozempic, but for patients without diabetes.
Ingesting small amounts of apple cider vinegar daily for three months helps control weight in overweight or obese people, according to a clinical trial involving 120 young Lebanese people. The results, published in the journal BMJ Nutrition, Prevention & Health, show that consumption of this substance - which has become fashionable among some celebrities - was associated with decreases in weight, body mass index and blood levels of glucose, triglycerides and cholesterol. The authors suggest that this substance could serve as a complementary treatment for obesity.
Eating more ultra-processed foods is linked to a higher risk of health problems, according to an umbrella review of 45 previous meta-analyses, involving almost 10 million people in total. The research, published in The BMJ, finds direct associations between exposure to ultra-processed foods and 32 health parameters. The strongest evidence links this exposure to cardiometabolic health problems, mental disorders and overall mortality.
Epigenetic editing is a technique that aims to alter gene expression without the need to modify the DNA sequence, as gene editing techniques do. In this way, Italian researchers have succeeded in silencing the PCSK9 gene in mice, thereby reducing cholesterol levels by half for at least a year. According to the authors, and assuming further evaluation is needed, their platform "could lay the foundations for the development of this type of therapy". The results are published in the journal Nature.
International research estimates that by 2024 there will be approximately 1,270,800 deaths from different types of cancer in the European Union (EU) as a whole. In the specific case of colorectal cancer, the researchers estimate that mortality rates will increase among people aged between 25 and 49 in the EU. In Spain, the increase will be 5.5 % in men. The authors of the research, published in the Annals of Oncology, attribute this increased mortality to overweight, obesity and alcohol consumption in this age group.
In the year 2023, Science magazine has chosen the development and discovery that GLP-1 medications, agonists of the glucagon-like peptide-1, can mitigate health issues associated with obesity as the most important scientific breakthrough. Similarly, Nature magazine has selected biochemist Svetlana Mojsov, a key figure in the discovery of GLP-1, as one of the top ten scientists of the year.
In Spain, both in the child and adult populations, excess weight and obesity are more prevalent among men. Additionally, lower educational levels, lower income, disability, and the presence of individuals with obesity in the household are factors associated with a higher prevalence of excess weight and obesity. These are some of the conclusions drawn from two scientific articles and two complementary reports prepared by the National Center for Epidemiology of the Carlos III Health Institute and the Spanish Agency for Food Safety and Nutrition (AESAN). The data is derived from the ENE-COVID survey, which investigated the seroprevalence of COVID-19 infection in Spain.